Clinical Trials Logo

Clinical Trial Summary

In this study, we test whether a two-week 8-session neutral attention bias modification (ABM) training and a two-week 4-session positive ABM could reduce depressive symptoms relative to placebo controls in adolescents with major depressive disorder at posttraining and follow-ups during one year.


Clinical Trial Description

Depression is a common health problem in adolescents. Negative attentional bias has been theorized to play a critical role in the onset and maintenance of depression, suggesting that reduction of such biases may treat symptoms of depression. Recent studies have shown that attention bias modification(ABM) training could reduce depressive symptoms in both dysphoria and previously depressed adult patients.To test the effectiveness of ABM training on the treatment of depressive symptoms in depressed adolescents, we designed a randomized, double-blind, placebo controlled trial in adolescents with major depressive disorder(MDD). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02078258
Study type Interventional
Source Hunan Normal University
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date July 2015

See also
  Status Clinical Trial Phase
Completed NCT01894815 - Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial Phase 3
Completed NCT01726387 - Self-Management for Anxiety, Depression and Somatoform Disorders N/A
Completed NCT01361815 - Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) N/A